Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Development and validation of a nomogram model based on vascular entry sign for predicting lymphovascular invasion in
Jing Zhang1, Peng-Hui Shen1, Jun-Bo Wu1
1Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Background:
To evaluate the predictive value of a nomogram based on the vascular entry sign for lymphovascular invasion in gastric cancer.
Methods:
A total of 135 patients with histopathologically confirmed gastric cancer from August 2021 to November 2022 were enrolled. All patients underwent contrast-enhanced CT scans. Utilizing a random number method, patients were randomly assigned to either a training dataset (n = 96) or a validation dataset (n = 39) in a 7:3 ratio. CT images and clinical characteristics of the patients were collected. Both univariate and multivariate analyses were conducted to identify independent factors influencing lymphovascular invasion in gastric cancer. A nomogram model was developed, and its diagnostic performance and clinical utility were assessed using receiver operating characterist (ROC) curves, calibration curves, and decision curve analysis (DCA).
Results:
The multivariate analysis revealed that the vascular entry sign, clinical T stage, and clinical N stage independently influenced the occurrence of factors for lymphovascular invasion in gastric cancer (P < 0.05). A predictive nomogram model was developed for determining LVI status in gastric cancer. The AUC of the nomogram model in the training dataset and validation dataset were 0.878 (95% CI: 0.808-0.948) and 0.866 (95% CI: 0.723-1.000), respectively. The calibration curve and decision curve showed that the model had good reliability and good clinical validity.
Conclusion:
The model established based on the factors of vascular entry sign, clinical T stage, and clinical N stage can effectively predict lymphovascular invasion in gastric cancer.

